Modulators of intestinal alkaline phosphatase

Area of Science:

• Biochemistry
• Pharmacology
• Enzyme Inhibitor Discovery

Background:

• Small molecule phosphatase modulators are valuable therapeutic agents and research tools.
• Intestinal alkaline phosphatases (IAPs) play critical roles in vivo, necessitating selective modulators for study.

Purpose of the Study:

• To develop lead discovery strategies for identifying inhibitors and activators of intestinal alkaline phosphatases.
• To identify isozyme-selective modulators for human and mouse IAPs.

Main Methods:

• Development of ultrahigh throughput chemiluminescent assays using CDP-Star substrate for mIAP, hIAP, PLAP, and TNAP.
• Concurrent high-throughput screening (HTS) of the MLSMR library (323,000 compounds) against human and mouse IAP isozymes.
• Structure-Activity Relationship (SAR) studies based on parallel analog testing against different alkaline phosphatase (AP) isozymes.

Main Results:

• Identification of a novel inhibitory scaffold selective for murine intestinal alkaline phosphatase (mIAP).
• Generation of a potent mIAP inhibitor with an IC50 of 540 nM.
• Achieved significant selectivity: at least 65-fold against human tissue-nonspecific alkaline phosphatase (TNAP) and >185-fold against human placental alkaline phosphatase (PLAP).

Conclusions:

• A selective and potent inhibitor of murine intestinal alkaline phosphatase was discovered through a parallel HTS approach.
• The identified inhibitor scaffold and SAR data provide a foundation for developing selective AP modulators.
• These findings enable further in vivo studies on the functional roles of mIAP.